Eli Lilly: The Story Is Already Everywhere - Don't Pay for Consensus
The Opportunity
This is a FADE-class idea by construction: the edge is decaying and the narrative is already spreading through mainstream channels. The right directional posture is not to invent a new LONG; it is to avoid getting emotionally pulled into a widely circulated development story that no longer offers information advantage. In a choppy, headline-sensitive regime, consensus stories generate volatility but rarely generate durable edge.
The Timing
Bearish 72 and crosswind 78 is where late-cycle story trading becomes a coin flip: you can be right on fundamentals and still lose on path. This remains AVOID until you either have a new primary artefact (trial readout, label change, regulator action) that is not already disseminated, or the story is translated into a specific, dated catalyst that has not yet propagated. Without that, the "trade" is just taking the other side of the crowd, and that is not what this workflow is for.
The Evidence
No hydrated evidence URLs are present for ED-008 in this payload, and it is explicitly routed as edge decay with a low information-edge score (0.22) and spreading lifecycle. That combination is enough to justify the FADE posture operationally: even if the underlying development is real, it is not an information-asymmetry product anymore.